Coronavirus

The JPEO's COVID-19 Support

Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)'s core focus areas contribute to building a more lethal force, a priority in the National Defense Strategy, and streamline JPEO-CBRND efforts to meet the Joint Service’s needs in combating chemical, biological, radiological and nuclear (CBRN) threats.

JPEO-CBRND is supporting our interagency partners in their response to the COVID-19 pandemic, from helping develop detection, diagnosis, treatment, and vaccines for our Warfighters, to tools that increase situational awareness of the coronavirus, all thanks to our team effort with industry and academia.

The JPEO-CBRND's Support to the National COVID-19 Response 


JPEO's and the Army's support to the COVID-19 response, with our partners, people, products & processes
Since the start of the pandemic, JPEO-CBRND's workforce has worked tirelessly to help procure and deliver COVID-19 medical countermeasures for the nation and the Joint Force. This snapshot captures our efforts in the National COVID-19 Response.

Download Our National COVID-19 Response Infographic

Quick Links

 

COVID News


Naval Surface Warfare Center, Crane Division - Heather Baladi, NSWC Crane

NSWC Crane employee serves public health overseeing $900M portfolio as U.S. expands vaccine and therapeutic manufacturing supply chain

News
Dec. 14, 2022

A Naval Surface Warfare Center, Crane Division (NSWC Crane) employee is serving on a detail overseeing a $900...
Read More
Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

DoD Awards $1.74 Billion Agreement to Moderna, Inc. to Secure Over 65 Million Doses of COVID-19 Vaccine for Fall Vaccinations

News
Jul. 29, 2022

On July 28, 2022, the Department of Defense (DoD), on behalf of and in coordination with the U.S. Department...
Read More
A servicemember sits in a yellow shirt in front of a table of red and blue testing vials. Covi

Biden-Harris Administration secures 3.2 million doses of Novavax COVID-19 Vaccine

News
Jul. 11, 2022

Latest vaccine will provide an additional option for the American public, pending FDA Emergency Use...
Read More
In the foreground a hand holding an orange sticker that says "I got my vaccine". In the background there are three medical personnel wearing personal protective equipment.

Biden-Harris Administration Secures More Than 100 Million Doses of Pfizer's Latest COVID-19 Vaccine for Fall Vaccine Campaign

News
Jun. 29, 2022

The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense (DOD),...
Read More
Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

DOD Awards $79.9 Million Contract to Premix, Inc. to Onshore Production Capacity of Resin for Pipette Tips Required for COVID-19 Diagnostic Testing

News
May. 11, 2022

On May 5, 2022, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of...
Read More
Two uniformed service members are in a tent. One wears PPE and a faceshield, while they use a nasal swab to collect a COVID-19 sample from the other Service member in uniform.

DoD Awards Contract Modifications to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS’ One Billion Free At-Home COVID-19 Tests

News
Mar. 28, 2022

In the month of March, the Department of Defense (DoD), in coordination with the U.S. Department of Health and...
Read More